跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Protein A (Degron)
首页
药物
Protein A (Degron)
Protein A (Degron)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS
EP 3313995 A1
申请人: AMYRIS INC
优先权: 2015
CN
EP
US
WO
16 件公开
Nonhuman animal and use for same
US 12522836 B2
申请人: INTER UNIV RESEARCH INSTITUTE CORPORATION RESEARCH ORGANIZATION OF INFORMATION AND SYSTEMS
优先权: 2019
EP
US
WO
8 件公开
STABILIZED PEPTIDE-MEDIATED TARGETED PROTEIN DEGRADATION
EP 3724216 A1
申请人: DANA FARBER CANCER INST INC
优先权: 2017
CN
EP
US
WO
6 件公开
BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS
EP 4536656 A4
申请人: C4 THERAPEUTICS INC
优先权: 2022
EP
US
WO
6 件公开
PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
EP 3898662 A4
申请人: DANA FARBER CANCER INST INC
优先权: 2018
EP
US
WO
4 件公开
GENE EDITING METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
EP 4100032 B1
申请人: BROAD INST INC
优先权: 2020
EP
US
WO
4 件公开
Method for robust control of gene expression
US 11820794 B2
申请人: CALIFORNIA INST OF TECHN
优先权: 2020
US
4 件公开
ANTI-PROTAC ANTIBODIES AND COMPLEXES
EP 4362976 A1
申请人: MERCK PATENT GMBH
优先权: 2021
EP
US
WO
3 件公开
METHOD FOR DEGRADING TARGET PROTEIN
EP 4674966 A1
申请人: INTER UNIV RESEARCH INSTITUTE CORPORATION RESEARCH ORGANIZATION OF INFORMATION AND SYSTEMS
优先权: 2023
EP
US
WO
3 件公开
COVALENT CEREBLON LIGANDS
EP 4801908 A1
申请人: C4 THERAPEUTICS INC
优先权: 2023
EP
US
WO
3 件公开
第 1 / 4 页
上一页
下一页
药物
反馈